Showing results (1341-1350 of 1,351) with videos related to
Sort By:
Pageof 136
Blood|February 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomesMichael C Zaiken, Ryan Flynn, Katelyn G Paz, et al.Future Microbiology|August 25, 2017
Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, ChinaLi-Na Guo, Meng Xiao, Bin Cao, et al.Nature Genetics|May 11, 2021
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Jin Zhou, Xiaoyang Zhang, et al.Molecular Cell|May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.Nature Chemical Biology|July 29, 2024
Template-assisted covalent modification underlies activity of covalent molecular gluesYen-Der Li, Michelle W Ma, Muhammad Murtaza Hassan, et al.Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.Nature|March 26, 2026
Dominant clones leverage developmental epigenomic states to drive ependymomaAlisha S Kardian, Hua Sun, Siri Ippagunta, et al.Nature Communications|June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.Cancer Discovery|October 28, 2022
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M GliomaEshini Panditharatna, Joana G Marques, Tingjian Wang, et al.Nature Genetics|October 2, 2012
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4Jianfeng Xu, Zengnan Mo, Dingwei Ye, et al.Pageof 136